Vitamin B12 status in hospitalised cancer patients: Prevalence and clinical implications of depletion and hypervitaminosis.

Autor: Sottotetti F; Medical Oncology Unit, Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Italy., Malovini A; Laboratory of Informatics and Systems Engineering for Clinical Research of the Institute of Pavia, Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Italy., Maccarone S; Medical Oncology Unit, Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Italy., Riva G; Medical Oncology Unit, Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Italy., Tibollo V; Laboratory of Informatics and Systems Engineering for Clinical Research of the Institute of Pavia, Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Italy., Palumbo R; Medical Oncology Unit, Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Italy., Tagliaferri B; Medical Oncology Unit, Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Italy., Bellazzi R; Laboratory of Informatics and Systems Engineering for Clinical Research of the Institute of Pavia, Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Italy; Department of Electrical, Computer and Biomedical Engineering, University of Pavia, Pavia, Italy., Cena H; Laboratory of Dietetics and Clinical Nutrition, Department of Public Health, Experimental and Forensic Medicine, University of Pavia, Pavia, Italy; Clinical Nutrition Unit, General Medicine, Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Italy., Di Sabatino A; Department of Internal Medicine and Medical Therapeutics, University of Pavia, Pavia, Italy; First Department of Internal Medicine, IRCCS San Matteo Hospital Foundation, Pavia, Italy., Locati LD; Medical Oncology Unit, Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Italy; Department of Internal Medicine and Medical Therapeutics, University of Pavia, Pavia, Italy., Lenti MV; Department of Internal Medicine and Medical Therapeutics, University of Pavia, Pavia, Italy; First Department of Internal Medicine, IRCCS San Matteo Hospital Foundation, Pavia, Italy. Electronic address: marco.lenti@unipv.it.

Publikováno v: Clinical nutrition ESPEN [Clin Nutr ESPEN] 2024 Oct; Vol. 63, pp. 585-594. Date of Electronic Publication: 2024 Jul 23.

Publisher Correction: Impact of doxorubicin-loaded ferritin nanocages (FerOX) vs. free doxorubicin on T lymphocytes: a translational clinical study on breast cancer patients undergoing neoadjuvant chemotherapy.

Autor: Sevieri M; Dipartimento di Scienze Biomediche e Cliniche, Università di Milano, Milan, 20157, Italy., Andreata F; Division of Immunology, Transplantation, and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy., Mainini F; Dipartimento di Scienze Biomediche e Cliniche, Università di Milano, Milan, 20157, Italy., Signati L; Dipartimento di Scienze Biomediche e Cliniche, Università di Milano, Milan, 20157, Italy.; Istituti Clinici Scientifici Maugeri IRCCS, Pavia, 27100, Italy., Piccotti F; Istituti Clinici Scientifici Maugeri IRCCS, Pavia, 27100, Italy., Truffi M; Istituti Clinici Scientifici Maugeri IRCCS, Pavia, 27100, Italy., Bonizzi A; Istituti Clinici Scientifici Maugeri IRCCS, Pavia, 27100, Italy., Sitia L; Dipartimento di Scienze Biomediche e Cliniche, Università di Milano, Milan, 20157, Italy., Pigliacelli C; Laboratory of Supramolecular and Bio-Nanomaterials (SBNLab), Department of Chemistry, Materials, and Chemical Engineering 'Giulio Natta', Politecnico di Milano, Milan, 20131, Italy., Morasso C; Istituti Clinici Scientifici Maugeri IRCCS, Pavia, 27100, Italy., Tagliaferri B; Istituti Clinici Scientifici Maugeri IRCCS, Pavia, 27100, Italy., Corsi F; Dipartimento di Scienze Biomediche e Cliniche, Università di Milano, Milan, 20157, Italy. fabio.corsi@unimi.it.; Istituti Clinici Scientifici Maugeri IRCCS, Pavia, 27100, Italy. fabio.corsi@unimi.it., Mazzucchelli S; Dipartimento di Scienze Biomediche e Cliniche, Università di Milano, Milan, 20157, Italy. serena.mazzucchelli@unimi.it.

Publikováno v: Journal of nanobiotechnology [J Nanobiotechnology] 2024 May 27; Vol. 22 (1), pp. 288. Date of Electronic Publication: 2024 May 27.

Efficacy and activity of treatments after progression from palbociclib plus endocrine therapy in patients with HR ⁺ /HER2 ^- metastatic breast cancer: a prospective, monocentric study.

Autor: Palumbo R; Medical Oncology Unit, ICS Maugeri-IRCCS SpA SB, Pavia, Italy., Quaquarini E; Medical Oncology Unit, ICS Maugeri-IRCCS SpA SB, Pavia, Italy., Saltalamacchia G; Medical Oncology Unit, ICS Maugeri-IRCCS SpA SB, Pavia, Italy.; Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy., Malovini A; Laboratory of Informatics and Systems Engineering for Clinical Research, ICS Maugeri-IRCCS SpA SB, Pavia, Italy., Lapidari P; Medical Oncology Unit, ICS Maugeri-IRCCS SpA SB, Pavia, Italy.; Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy., Tagliaferri B; Medical Oncology Unit, ICS Maugeri-IRCCS SpA SB, Pavia, Italy., Mollica L; Medical Oncology Unit, ICS Maugeri-IRCCS SpA SB, Pavia, Italy.; Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy., Teragni CM; Medical Oncology Unit, ICS Maugeri-IRCCS SpA SB, Pavia, Italy., Barletta C; Medical Oncology Unit, ICS Maugeri-IRCCS SpA SB, Pavia, Italy.; Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy., Locati LD; Medical Oncology Unit, ICS Maugeri-IRCCS SpA SB, Pavia, Italy.; Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy., Sottotetti F; Medical Oncology Unit, ICS Maugeri-IRCCS SpA SB, Pavia, Italy.

Publikováno v: Drugs in context [Drugs Context] 2024 Feb 05; Vol. 13. Date of Electronic Publication: 2024 Feb 05 (Print Publication: 2024).

Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as second-line chemotherapy in HER2-negative, taxane-pretreated metastatic breast cancer patients: prospective evaluation of activity, safety, and quality of life

Autor: Palumbo R, Sottotetti F, Trifirò G, Piazza E, Ferzi A, Gambaro A, Spinapolice EG, Pozzi E, Tagliaferri B, Teragni C, Bernardo A

Publikováno v: Drug Design, Development and Therapy, Vol 2015, Iss default, Pp 2189-2199 (2015)

Raffaella Palumbo,1 Federico Sottotetti,1 Giuseppe Trifirò,2 Elena Piazza,3 Antonella Ferzi,4 Anna Gambaro,3 Elena Giulia Spinapolice,2 Emma Pozzi,1 Barbara Tagliaferri,1 Cristina Teragni,1 Antonio Bernardo1 1Departmental Unit of Oncology, IRCCS Fon

Externí odkaz: https://doaj.org/article/cb0d3f4ad43748d1ba678f8876046d56

Low neutrophil-to-lymphocyte ratio and pan-immune-inflammation-value predict nodal pathologic complete response in 1274 breast cancer patients treated with neoadjuvant chemotherapy: a multicenter analysis.

Autor: Gasparri ML; Department of Gynecology and Obstetrics, Ospedale Regionale di Lugano EOC, Lugano, Switzerland.; Centro di Senologia della Svizzera Italiana, Ospedale Regionale di Lugano EOC, Lugano, Switzerland., Albasini S; Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Italy., Truffi M; Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Italy., Favilla K; Scuola di specializzazione in Chirurgia Generale, Università di Milano, Milano, Italy., Tagliaferri B; Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Italy., Piccotti F; Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Italy., Bossi D; Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Italy., Armatura G; Chirurgia Generale, Ospedale Centrale di Bolzano, Azienda Sanitaria dell'Alto Adige, Bolzano, Italy., Calcinotto A; Institute of Oncology Research (IOR), Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.; Università della Svizzera italiana, Faculty of Biomedical Sciences, Lugano, Switzerland., Chiappa C; SSD Breast Unit, ASST-Settelaghi di Varese, Varese, Italy., Combi F; International PhD School in Clinical and Experimental Medicine (CEM), University of Modena and Reggio Emilia, Modena, Italy.; Division of Breast Surgical Oncology, Department of Medical and Surgical, Maternal-Infantile and Adult Sciences, University Hospital of Modena, Modena, Italy., Curcio A; Chirurgia Senologica, Ospedale Morgagni Pierantoni, Ausl Romagna, Forlì, Italy., Della Valle A; General Surgery 3- Breast Surgery, Department of Surgery, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Ferrari G; Breast Surgery Unit, AUSL-IRCCS Reggio Emilia, Reggio Emilia, Italy., Folli S; Breast Unit, Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Ghilli M; Breast Cancer Centre, University Hospital of Pisa, Pisa, Italy., Listorti C; Breast Unit, Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Mancini S; Breast Surgery, Department of Surgery, ASST Fatebenefratelli Sacco, Milano, Italy., Marinello P; Chirurgia Generale, Ospedale Centrale di Bolzano, Azienda Sanitaria dell'Alto Adige, Bolzano, Italy., Mele S; Breast Surgery Unit, AUSL-IRCCS Reggio Emilia, Reggio Emilia, Italy., Pertusati A; Breast Surgery, Department of Surgery, ASST Fatebenefratelli Sacco, Milano, Italy., Roncella M; Breast Cancer Centre, University Hospital of Pisa, Pisa, Italy., Rossi L; Centro di Senologia della Svizzera Italiana, Ospedale Regionale di Lugano EOC, Lugano, Switzerland.; Institute of Oncology of Southern Switzerland (IOSI), Bellinzona, Switzerland., Rovera F; SSD Breast Unit, ASST-Settelaghi di Varese, Varese, Italy., Segattini S; Division of Breast Surgical Oncology, Department of Medical and Surgical, Maternal-Infantile and Adult Sciences, University Hospital of Modena, Modena, Italy., Sgarella A; General Surgery 3 - Breast Surgery, Department of Surgery, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.; Università degli studi di Pavia, Pavia, Italy., Tognali D; Chirurgia Senologica, Ospedale Morgagni Pierantoni, Ausl Romagna, Forlì, Italy., Corsi F; Istituti Clinici Scientifici Maugeri IRCCS, Via Maugeri 4, Pavia, Lombardia, Italy.; Dipartimento di Scienze Biomediche e Cliniche, Università di Milano, Milano, Italy.

Publikováno v: Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2023 Sep 15; Vol. 15, pp. 17588359231193732. Date of Electronic Publication: 2023 Sep 15 (Print Publication: 2023).